Like nPruv, Inc.

closed 1/7/2016 via BNC Analysis

Parallel 6, acquired nPruv, Inc.

synopsis: Parallel 6, the leading provider of mobile clinical solutions, announced its acquisition of nPruv, Inc., the developer of a patient matching and predictive modeling solution for clinical trial patient recruitment.
buyer: Parallel 6
Parallel 6, is an innovative software as a service provider of mobile enrollment & engagement solutions for clinical research, health, and public sector organizations. Clinical Reach is an end-to-end patient centric engagement platform for the healthcare and life sciences industries. "
target: nPruv, Inc.
nPruv's online marketplace and in-clinic solution matches patients and doctors with available clinical trial opportunities. nPruv is a Health IT company enabling a new era of predictive modeling for clinical trial patient matching and recruitment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/22/2013 via PR Newswire

Connecture, Inc., acquired DRX

synopsis: Connecture, Inc., the leader in sales automation technology for the health insurance industry, announced it acquired DRX (formerly known as DestinationRx), a provider of Web-based shopping and enrollment systems for consumers of Medicare health plans, as well as those used to compare name brand pharmaceuticals with therapeutic alternatives.
buyer: Connecture, Inc. (OTCQX:CNXR:$77.99)
Connecture is the leading provider of Web-based information systems used to create health insurance marketplaces and exchanges. Its industry-proven solutions enable consumers, employers and brokers to more easily shop for, purchase and renew health insurance. "
target: DRX
Established in 1999, DRX is the leading provider of technology solutions for web-based prescription drug comparison as well as Medicare health plan comparison and enrollment services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2020 via BNC Analysis

Raia Drogasil S.A., acquired Manipulaê

synopsis: The drugstore chain Raia Drogasil, the sector's leader in Brazil, announced the launch of a health products marketplace as part of a plan to leverage its e-commerce businesses. Raia Drogasil acquired the purchase of the startup Manipulaê as part of this initiative. Manipulaê is a pharmacy comparison portal for Brazilians.
buyer: Raia Drogasil S.A. (BOVESPA:RADL3:$3,372.87)
Raia Drogasil is a leading company in the Brazilian pharmacy market, with over 2,100 stores in 23 Brazilian states. The company was created in November 2011, after the merger between Raia SA and Drogasil SA. "
target: Manipulaê
Manipulaê believes in the power of technology to bring well-being and healthier life to all Brazilians. Find out about pharmacies, see reviews from other consumers, contact details and make payment online safely.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/20/2018 via GlobeNewswire

Geopulse Exploration, Inc., will acquire THCFinder.com

synopsis: Geopulse Exploration, Inc., doing business as CannCo Brands & Development and Growth Circle, Inc., announced that it has reached agreement to acquire all of the assets related to www.THCFinder.com, an advertising and marketing site that geo-targets dispensaries, delivery services, and cannabis related physicians offices.
buyer: Geopulse Exploration, Inc. (OTCPK:GPLS:$0.00)
Geopulse Exploration, doing business as CannCo Brands & Development, acquired Growth Circle in 2017. Growth Circle, Inc. develops and distributes marketing and financial content for emerging growth companies including medicinal cannabis-related entities. "
target parent: Endexx
target: THCFinder.com
THCFinder.com helps medical marijuana patients find better access to reliable and safe medication and provides a web platform for patients to interact and feel at ease in a community of users.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/13/2020 via BusinessWire

Press Ganey Associates, Inc., acquired Doctor.com

synopsis: Press Ganey, an integrated suite of solutions that enables enterprise transformation across the patient journey, has acquired Doctor.com, a platform built to help healthcare organizations deliver a better customer experience at every step of the patient journey.
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement. "
target parent: Spring Capital Partners, L.P.
target: Doctor.com
Doctor.com is a platform built to help healthcare organizations deliver a better customer experience at every step of the patient journey. The company's industry-leading technology seamlessly integrates provider data warehousing, web-wide listings management, reputation insights, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/22/2017 via Reuters

iFlag Co., Ltd., will acquire Dr. O-uccino

synopsis: iFLAG Co.,Ltd., a company that provides IT solutions to small businesses in Japan, has acquired Dr. O-uccino from O-uccino. Dr. O-uccino operates a doctor and hospital search engine site and is located in Tokyo, Japan. People can search by hospital, specialty, location and doctor name.
buyer parent: Hikari Tsushin, Inc.
buyer: iFlag Co., Ltd. (2759:$53.65)
iFLAG Co.,Ltd. provides IT solutions to small businesses in Japan. The company plans, produces, operates, and supports home-services business based on cloud computing. "
target parent: O-uccino
target: Dr. O-uccino
Dr. O-uccino operates a doctor and hospital search engine site and is located in Tokyo, Japan. People can search by hospital, specialty, location and doctor name.
price ($mm)
$0.18
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2016 via PR Newswire

FairMedOnline, acquired Caremondo GmbH

synopsis: FairMedOnline, a digital healthcare company based in Singapore offering neutral medical second opinions for patients, acquired the international medical tourism platform Caremondo. Caremondo is a full-service global platform for high-quality medical travel that allows patients to compare and book medical, dental, and aesthetic treatments abroad.
buyer: FairMedOnline
FairMedOnline (FMO) is a digital healthcare company based in Singapore. It offers independent medical second opinions and online access to more than 100 renowned German specialists for patients across Asia, the Middle East and Africa. "
target: Caremondo GmbH
Caremondo is a full-service global digital marketplace for high-quality medical travel. Patients can compare medical, dental, and aesthetic treatments and book appointments in more than 160 verified hospitals worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/26/2015 via BNC Analysis

Global Health and Travel, acquired Tab a Doctor

synopsis: Global Health and Travel, a medical directory and media firm dedicated to medical travel and health tourism in Asia, announced it acquired Tab a Doctor, a company that helps Indonesian patients find and communicate with reputable doctors in Singapore and Malaysia.
buyer: Global Health and Travel
Global Health and Travel is a medical directory and media firm dedicated to medical travel and health tourism in Asia. It is located in Singapore. "
target: Tab a Doctor
Tab a Doctor helps Indonesian patients find and communicate with reputable doctors in Singapore and Malaysia, where the healthcare systems are arguably more sophisticated than those in Indonesia.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2021 via GlobeNewswire

Accolade, Inc., acquired 2ndMD

synopsis: Accolade, Inc., which provides personalized, technology-enabled solutions that help people better understand, navigate and utilize the healthcare system and their workplace benefits, announced it has acquired 2nd.MD, a leading Expert Medical Opinion and medical decision support company based in Houston, TX.
buyer: Accolade, Inc. (:$155.57)
Accolade provides personalized advocacy solutions that improve the experience and cost of healthcare for employers, health plans, and members. Accolade connects personal health data and programs to present a single point of entry to health and benefits resources while coordinating with providers. "
target: 2ndMD
2nd.MD is a revolutionary online resource that connects consumers with the nation’s leading medical specialists for second opinions.
price ($mm)
$338
rev ($mm)
$35
EBITDA ($mm)
EV / rev
12.4x
EV / EBITDA
closed 11/11/2020 via PR Web

ProtoCall Services Inc., acquired The Shrink Space

synopsis: ProtoCall Services, the leading provider of telephonic crisis intervention and behavioral health assessment services, announced its acquisition of The Shrink Space, a referral management software platform that is widely used in higher education.
buyer: ProtoCall Services Inc.
For more than 25 years, ProtoCall Services has provided 24/7 telephonic crisis intervention support for universities, colleges, community health organizations and employer benefits providers. Its seamless and customized services. "
target: The Shrink Space
The Shrink Space is a female-founded, HIPAA- and VPAT-compliant software platform that streamlines the behavioral health referral life cycle for institutions, clients and community providers. The Shrink Space is a referral management software platform that is widely used in higher education.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

Medinet Australia, acquired Patient Connector

synopsis: Medinet, a 24/7 GP telehealth consultation app, has acquired Patient Connector, an online platform that directly connects patients with specialist doctors and aims to increase transparency around specialists’ fees and waitlists.
buyer: Medinet Australia
Based in Australia, Medinet is a 24/7 GP telehealth consultation app, that allows patients to obtain clinical advice from a GP; access prescriptions and have medications delivered; access pathology results and directly email their medical certificate to employers; and access specialist referrals. "
target: Patient Connector
Patient Connector is an online platform that directly connects patients with specialist doctors and aims to increase transparency around specialists’ fees and waitlists. Patients can find a specialist doctor at the price, availability and location which best suits them.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2018 via PR Newswire

WebMD Corporation, purchased Consumer Services Division from Vitals, Inc

synopsis: WebMD, an Internet Brands company, announced that it has acquired Vitals Consumer Services Division from MDx Medical, Inc/Vitals, Inc. Vitals Consumer Services Division helps consumers find local healthcare professionals and also have a collection of online patient-to-patient communities that enable daily conversations about medical conditions.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: WebMD Corporation (WBMD:$700.55)
WebMD Health Corp., an Internet Brands Company, is the leading provider of health information services, serving patients, physicians, health care professionals, employers, and health plans through their public and private online portals, mobile platforms, and health-focused publications. "
seller: Vitals, Inc
Vitals Consumer Services Division helps consumers find local healthcare professionals for themselves and their families. They also have a collection of online patient-to-patient communities that enable tens of thousands of daily conversations about hundreds of medical conditions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/8/2017 via BNC Analysis

Schlutersche Verlagsgesellschaft mbH & Co. KG, acquired DocInsider GmbH

synopsis: Schlütersche Verlagsgesellschaft, a company that operates as a publishing house offering yellow pages, technical books, and trade publications, has acquired DocInsider GmbH, a company that operates an online health platform for evaluation of physicians. It develops a portal for patients and has a database of 300,000 physicians.
buyer: Schlutersche Verlagsgesellschaft mbH & Co. KG
Schlütersche Verlagsgesellschaft mbH & Co. KG operates as a publishing house offering yellow pages, technical books, and trade publications. The company was founded in 1747 and is based in Hanover, Germany. "
target: DocInsider GmbH
DocInsider GmbH operates an online health platform for evaluation of physicians. It develops a portal for patients and has a database of 300,000 physicians and related professionals in Germany. The company was founded in 2007 and is based in Hamburg, Germany.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2015 via GlobeNewswire

Hubert Burda Media, acquired jameda

synopsis: TOMORROW FOCUS AG has agreed to sell jameda GmbH, which operates a physician ratings portal by the same name, to Burda Digital GmbH. jameda is Germany's biggest physician ratings portal. Over five million patients use the portal every month to find the right physician.
buyer: Hubert Burda Media
Responsible for over 400 print and digital consumer brands, Hubert Burda Media is one of Germany's largest media groups. It publishes more than 320 magazines around the globe. Burda has 165 million users, approximately 40 million paying consumers and 43,000 advertisers. "
target parent: Tomorrow Focus AG
target: jameda
jameda is the leading physician rating website in Germany. The website is used by over 5 million patients to search for the right doctor through a database of more than 250,000 medical professionals across Germany.
price ($mm)
$50
rev ($mm)
$5
EBITDA ($mm)
$1
EV / rev
10.1x
EV / EBITDA
37.8x
closed 10/28/2014 via Company Press Release

Vitals, Inc, acquired Compass Healthcare Advisers

synopsis: Vitals, a leader in providing online transparency tools and data, helping consumers make informed decisions about their medical care, announced that it has acquired Compass Healthcare Advisers. Compass educates patients about the huge price differentials for common inpatient and outpatient health care services in their area.
buyer: Vitals, Inc
Vitals is reinventing the way people choose doctors and medical facilities. They provide increased transparency to cost, quality and access information to support effective decision making. Vitals brings together actionable data, online tools and an engaging consumer experience. "
target: Compass Healthcare Advisers
Compass educates patients about the huge price differentials for common inpatient and outpatient health care services in their area, then provides the tools to quickly and easily shop hundreds of services based on price, quality and location.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2021 via BNC Analysis

Vespa Capital, acquired SelectScience

synopsis: Vespa Capital, a UK private equity investor, has acquired SelectScience Limited. Bath based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
buyer: Vespa Capital
Vespa Capital is an established Private Equity investor in the UK lower mid-market. With over £200m of funds under management, they focus on Management Buy Outs and recapitalisations of privately owned businesses with an Enterprise Value between £10m and £70m. "
target: SelectScience
Bath-based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2019 via BNC Analysis

Carelabs Co., Ltd., acquired Eunogo Pte Ltd

synopsis: Carelabs, a South Korea-based digital beauty and healthcare company, has acquired 53 per cent of Eunogo, a local online beauty and wellness concierge startup with offices in Korea, Singapore and Indonesia. Eunogo runs a premium virtual assistant service for arranging aesthetic procedures.
buyer: Carelabs Co., Ltd. (KOSDAQ:A263700:$49.51)
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions. "
target: Eunogo Pte Ltd
Founded in 2015, Eunogo runs a premium virtual assistant service for arranging aesthetic procedures in Korea. The company shares its connections and expertise with foreigners who wish to visit Korea for plastic surgery and aesthetical touchups, providing access to top-tier doctors and VIP care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via PR Newswire

SimplaFYI, acquired EthosWell LLC

synopsis: SimplaFYI, a health and wellbeing company focused on advancing health through integrative care, has acquired EthosWell, a Massachusetts company focused on acupuncture, chiropractic and nutrition. EthosWell is an online platform that helps people find, book, and pay for appointments with local chiropractors, acupuncturists, and dietitians.
buyer: SimplaFYI
SimplaFYI was founded to advance health and wellbeing through integrative care. SimplaFYI partners with practitioners of acupuncture, chiropractic, massage|bodywork, meditation|mindfulness, yoga and nutrition to provide preferred pricing to members. "
target: EthosWell LLC
EthosWell is an online platform that helps people find, book, and pay for appointments with local chiropractors, acupuncturists, and dietitians. Their mission is to increase the access to complementary healthcare and promote evidence-based and clinical education around these types of therapies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/27/2019 via BNC Analysis

Docavenue, acquired RDV Médicaux

synopsis: Docavenue, a subsidiary of the Cegedim group specializing in the teleconsultation of doctors, announced the acquisition of the online appointments site RDVMédicaux, which belonged to Vivendi. 
buyer parent: Cegedim
buyer: Docavenue
Docavenue, a subsidiary of the Cegedim group, is specialized in the teleconsultation of doctors. Some 500 doctors are currently using Docavenue's teleconsultation tool. Docavenue is based in Boulogne-Billancourt, France. "
target parent: Vivendi SA
target: RDV Médicaux
RDV Médicaux, based in Paris, is an online platform lets users make an appointment with a doctor anywhere in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via BNC Analysis

Doctena, acquired Mednanny

synopsis: The Luxembourg-based online medical booking service Doctena has taken over the operations of the Austrian leader Mednanny.com. Mednanny is an interactive health platform. Mednanny allows its users to arrange their doctor's appointments online - for free and completely safely.
buyer: Doctena
Doctena is a platform dedicated to helping patients find doctors and organize an appointment with them. They make the best use of the newest online and mobile technologies in order to help reduce wait time for patients to see a doctor. "
target: Mednanny
Mednanny is an interactive health platform. Mednanny allows its users to arrange their doctor's appointments online - for free and completely safely.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2016 via BNC Analysis

Parallel 6, acquired nPruv, Inc.

synopsis: Parallel 6, the leading provider of mobile clinical solutions, announced its acquisition of nPruv, Inc., the developer of a patient matching and predictive modeling solution for clinical trial patient recruitment.
buyer: Parallel 6
Parallel 6, is an innovative software as a service provider of mobile enrollment & engagement solutions for clinical research, health, and public sector organizations. Clinical Reach is an end-to-end patient centric engagement platform for the healthcare and life sciences industries. "
target: nPruv, Inc.
nPruv's online marketplace and in-clinic solution matches patients and doctors with available clinical trial opportunities. nPruv is a Health IT company enabling a new era of predictive modeling for clinical trial patient matching and recruitment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2016 via BNC Analysis

Parallel 6, acquired nPruv, Inc.

synopsis: Parallel 6, the leading provider of mobile clinical solutions, announced its acquisition of nPruv, Inc., the developer of a patient matching and predictive modeling solution for clinical trial patient recruitment.
buyer: Parallel 6
Parallel 6, is an innovative software as a service provider of mobile enrollment & engagement solutions for clinical research, health, and public sector organizations. Clinical Reach is an end-to-end patient centric engagement platform for the healthcare and life sciences industries. "
target: nPruv, Inc.
nPruv's online marketplace and in-clinic solution matches patients and doctors with available clinical trial opportunities. nPruv is a Health IT company enabling a new era of predictive modeling for clinical trial patient matching and recruitment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2015 via PR Web

Parallel 6, acquired The Agency San Diego

synopsis: Parallel 6, a creative enterprise mobile technology company that specializes in Mobile Engagement Management solutions, announced the acquisition of The Agency San Diego, a creative agency that specializes in strategic, creative marketing and design.
buyer: Parallel 6
Parallel 6 specializes in Mobile Engagement Management solutions. They offer Captive Reach, an enterprise strength mobile technology platform that empowers clinical trials, government reach and many other vertical based solutions to influence consumer behavior, enhance brand recognition, and more. "
target: The Agency San Diego
The Agency San Diego is an advertising agency that specializes in all things creative. Founded in 2004, the creative firm provides end-to-end strategic marketing and advertising through interactive designs and concepts for digital, web and mobile.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via PR Newswire

The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.

synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
target: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2014 via PR Newswire

BioClinica, Inc., acquired Blueprint Clinical

synopsis: BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization, electronic data capture, randomization, and clinical trial management. "
target: Blueprint Clinical
Blueprint Clinical, Inc. creates Software-as-a-Service tools that help improve monitoring of clinical trials. Their first product, Blueprint Clinical Compass™, ultimately allows risk based monitoring implementation thereby improving quality and efficiency of clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/29/2012 via Market Wire

Oracle Corporation, will acquire ClearTrial, LLC.

synopsis: Oracle announced that it has entered into an agreement to acquire ClearTrial, a leading provider of cloud-based Clinical Trial Operations (CTO) applications that make the planning, sourcing, and tracking of clinical projects and financial performance faster and more accurate.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle Corporation is the world's largest enterprise software company. The company is a leading provider of systems software, including database management, application development, and application server software. "
target: ClearTrial, LLC.
ClearTrial, LLC provides software-as-a-service based Clinical Trial Operations software for planning, forecasting, and tracking clinical project and financial performance. The company serves biopharmaceutical companies, CROs, medical device companies, and small biotechs worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like nPruv, Inc.


read more

nPruv, Inc.

DRX

Manipulaê

THCFinder.com

Doctor.com

Dr. O-uccino

Caremondo GmbH

Tab a Doctor

2ndMD

The Shrink Space

Patient Connector

Vitals, Inc

DocInsider GmbH

jameda

Compass Healthcare Advisers

SelectScience

Eunogo Pte Ltd

EthosWell LLC

RDV Médicaux

Mednanny

read more

nPruv, Inc.

read more

Parallel 6

nPruv, Inc.

The Agency San Diego

read more

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

Sylogent

Parallel 6

SecureConsent

Clinverse, Inc.

Medsight Solutions Inc.

ClinIntel Ltd.

ePharmaSolutions, Inc.

Blueprint Clinical

DecisionView, Inc.

ClearTrial, LLC.

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.71
EBITDA ($mm)
$6.69
EBIT ($mm)
$5.66
Net Income ($mm)
$0.47
Employees
268
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch